Identification of SARS-CoV-2–specific immune alterations in acutely ill patients

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2020.12.21.20248642: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board StatementConsent: Informed consent was obtained for each patient and is detailed elsewhere(86).
    RandomizationMultivariate prediction of the SARS-CoV-2+, SARS-CoV-2neg and HC status, using as candidate predictor variables the whole set of the immune subpopulations, was performed using a random forest (52) classification models as implemented in the randomForest 4.6-14 R package using 1000 random trees and the default “mtry” (number of variables randomly sampled and tested in each node) parameter.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    Software and Algorithms
    SentencesResources
    BD FACSDiva™ CS&T research beads (#655051) were acquired biweekly to ensure the stability of the cytometer.
    BD FACSDiva™
    suggested: (BD FACSDiva Software, RRID:SCR_001456)
    Flow cytometry analysis: Flow cytometric data analysis was performed using FlowJo (version 10.6.2).
    FlowJo
    suggested: (FlowJo, RRID:SCR_008520)
    Using the R packages flowCore 2.0.1 and FlowSOM 1.20.0 in R version 4.0.1, we applied the FlowSOM algorithm(20) on these concatenated files to create a FlowSOM map for each panel.
    flowCore
    suggested: (flowCore, RRID:SCR_002205)
    The modal value of clusters, as determined by the PhenoGraph clustering algorithm(19) in FlowJo on multiple random samples, was used to determine the number of clusters to input into FlowSOM.
    PhenoGraph
    suggested: (Phenograph, RRID:SCR_016919)
    FlowSOM
    suggested: (FlowSOM, RRID:SCR_016899)

    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.

    Results from TrialIdentifier: We found the following clinical trial numbers in your paper:

    IdentifierStatusTitle
    NCT04356508Not yet recruitingCOVID-19: A Pilot Study of Adaptive Immunity and Anti-PD1


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: Please consider improving the rainbow (“jet”) colormap(s) used on page 39. At least one figure is not accessible to readers with colorblindness and/or is not true to the data, i.e. not perceptually uniform.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.